Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

HER2-positive Breast Cancer × Biopsy × 90 days × Clear all

Sponsor

Conditions

Neoplasm Metastasis 34 Leukemia, Myeloid, Acute 26 Multiple Myeloma 23 Colorectal Neoplasms 18 Breast Neoplasms 18 Prostatic Neoplasms 17 Triple Negative Breast Neoplasms 14 Lymphoma 14 Pancreatic Neoplasms 13 Ovarian Neoplasms 12 Melanoma 12 Myelodysplastic Syndromes 11 Lung Neoplasms 11 Leukemia, Lymphocytic, Chronic, B-Cell 10 Carcinoma, Non-Small-Cell Lung 10 Lymphoma, Large B-Cell, Diffuse 9 Burkitt Lymphoma 9 Neuroblastoma 8 Myeloproliferative Disorders 8 Fallopian Tube Neoplasms 8 Endometrial Neoplasms 8 Lymphoma, Non-Hodgkin 7 Leukemia, Myelomonocytic, Chronic 7 Carcinoma, Renal Cell 7 Squamous Cell Carcinoma of Head and Neck 6 Sarcoma 6 Neoplasms 6 Myelodysplastic-Myeloproliferative Diseases 6 Lymphoma, Follicular 6 Glioma 6

Interventions

pertuzumab 2 Trastuzumab 2 tucatinib 1 pyrotinib 1 Paclitaxel 1 Fluorodeoxyglucose F18 1 Docetaxel 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡